The importance of RIPK1 kinase activity in inflammation arising from loss FADD or caspase-8 loss underscores the therapeutic potential of targeting the kinase activity of RIPK1 in CASP8 mutant patients with VEO-IBD. The gene discussed is CASP8; the disease is inflammatory bowel disease.